urea has been researched along with Carcinoma, Renal Cell in 13 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
Excerpt | Relevance | Reference |
---|---|---|
"Clear cell renal cell carcinoma (ccRCC) is a major cancer yet has long evaded extensive efforts to target it chemotherapeutically." | 2.66 | Molecular Components of the RCC Grade. ( Ishimaru, T, 2020) |
"With the exception of Renal Cell Carcinoma (RCC), NPCaT demonstrated no or low PSMA expression." | 1.72 | Non-prostate cancer tumours: incidence on ( O'Connor, D; Perry, E; Sharma, S; Sutherland, TR; Talwar, A; Taubman, K; Wong, LM, 2022) |
"The most common subtype is "clear cell" renal cell carcinoma (ccRCC), which features consistent metabolic abnormalities, such as highly elevated glycogen and lipid deposition." | 1.48 | Arginase 2 Suppresses Renal Carcinoma Progression via Biosynthetic Cofactor Pyridoxal Phosphate Depletion and Increased Polyamine Toxicity. ( Ackerman, D; Alwine, JC; Blair, IA; Daisak, JI; Hess, M; Keith, B; Khare, S; Lee, P; Li, B; Lin, N; Maguire, TG; Nathanson, KL; Nissim, I; Ochocki, JD; Qiu, B; Simon, MC; Worth, AJ; Wubbenhorst, B; Xie, H, 2018) |
"In a renal cell carcinoma cell (RCC) line, bidirectional exchange was observed." | 1.42 | Dynamic UltraFast 2D EXchange SpectroscopY (UF-EXSY) of hyperpolarized substrates. ( Koelsch, B; Kurhanewicz, J; Larson, P; Leon Swisher, C; Santos, RD; Sriram, R; Sukumar, S; Vigneron, D; Wang, ZJ, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (7.69) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (15.38) | 29.6817 |
2010's | 5 (38.46) | 24.3611 |
2020's | 5 (38.46) | 2.80 |
Authors | Studies |
---|---|
Currie, GM | 1 |
Trifunovic, M | 1 |
Liu, J | 1 |
Kim, S | 1 |
Gurney, H | 1 |
Perry, E | 1 |
Talwar, A | 1 |
Sharma, S | 1 |
O'Connor, D | 1 |
Wong, LM | 1 |
Taubman, K | 1 |
Sutherland, TR | 1 |
Ishimaru, T | 1 |
Liu, Y | 1 |
Wang, G | 1 |
Yu, H | 1 |
Wu, Y | 1 |
Lin, M | 1 |
Gao, J | 1 |
Xu, B | 1 |
Sun, Y | 1 |
Li, J | 1 |
Qu, Z | 1 |
Yang, Z | 1 |
Jia, X | 1 |
Lin, Y | 1 |
He, Q | 1 |
Zhang, L | 1 |
Luo, Y | 1 |
Ochocki, JD | 1 |
Khare, S | 1 |
Hess, M | 1 |
Ackerman, D | 1 |
Qiu, B | 1 |
Daisak, JI | 1 |
Worth, AJ | 1 |
Lin, N | 1 |
Lee, P | 1 |
Xie, H | 1 |
Li, B | 1 |
Wubbenhorst, B | 1 |
Maguire, TG | 1 |
Nathanson, KL | 1 |
Alwine, JC | 1 |
Blair, IA | 1 |
Nissim, I | 1 |
Keith, B | 1 |
Simon, MC | 1 |
Leon Swisher, C | 1 |
Koelsch, B | 1 |
Sukumar, S | 1 |
Sriram, R | 1 |
Santos, RD | 1 |
Wang, ZJ | 1 |
Kurhanewicz, J | 1 |
Vigneron, D | 1 |
Larson, P | 1 |
Rowe, SP | 3 |
Gorin, MA | 3 |
Hammers, HJ | 3 |
Som Javadi, M | 1 |
Hawasli, H | 1 |
Szabo, Z | 2 |
Cho, SY | 1 |
Pomper, MG | 3 |
Allaf, ME | 3 |
Javadi, MS | 1 |
Hooper, JE | 1 |
Kates, M | 1 |
Lacouture, ME | 1 |
Reilly, LM | 1 |
Gerami, P | 1 |
Guitart, J | 1 |
Bilim, V | 1 |
Ougolkov, A | 1 |
Yuuki, K | 1 |
Naito, S | 1 |
Kawazoe, H | 1 |
Muto, A | 1 |
Oya, M | 1 |
Billadeau, D | 1 |
Motoyama, T | 1 |
Tomita, Y | 1 |
GOLDBERG, MF | 1 |
TASHJIAN, AH | 1 |
ORDER, SE | 1 |
DAMMIN, GJ | 1 |
1 review available for urea and Carcinoma, Renal Cell
Article | Year |
---|---|
Molecular Components of the RCC Grade.
Topics: Basic Helix-Loop-Helix Transcription Factors; Biomarkers, Tumor; Carcinoma, Renal Cell; Cellular Rep | 2020 |
1 trial available for urea and Carcinoma, Renal Cell
Article | Year |
---|---|
Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted ¹⁸F-DCFPyL PET/CT.
Topics: Aged; Antigens, Surface; Carcinoma, Renal Cell; Glutamate Carboxypeptidase II; Humans; Kidney Neopla | 2015 |
11 other studies available for urea and Carcinoma, Renal Cell
Article | Year |
---|---|
Topics: Carcinoma, Renal Cell; Humans; Kidney Neoplasms; Ligands; Lysine; Male; Positron Emission Tomography | 2022 |
Non-prostate cancer tumours: incidence on
Topics: Carcinoma, Renal Cell; Humans; Incidence; Kidney Neoplasms; Lysine; Male; Positron Emission Tomograp | 2022 |
Comparison of 18F-DCFPyL and 18F-FDG PET/computed tomography for the restaging of clear cell renal cell carcinoma: preliminary results of 15 patients.
Topics: Aged; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lysine; Male; | 2020 |
Causal Associations between Serum Urea and Cancer: A Mendelian Randomization Study.
Topics: Breast Neoplasms; Carcinoma, Renal Cell; Female; Genome-Wide Association Study; Humans; Kidney Neopl | 2021 |
Arginase 2 Suppresses Renal Carcinoma Progression via Biosynthetic Cofactor Pyridoxal Phosphate Depletion and Increased Polyamine Toxicity.
Topics: Animals; Arginase; Argininosuccinate Synthase; Carcinoma, Renal Cell; Cell Line, Tumor; Gene Express | 2018 |
Dynamic UltraFast 2D EXchange SpectroscopY (UF-EXSY) of hyperpolarized substrates.
Topics: Alanine; Carcinoma, Renal Cell; Cell Line, Tumor; Enzyme Inhibitors; Enzymes; Humans; Kidney Neoplas | 2015 |
Detection of 18F-FDG PET/CT Occult Lesions With 18F-DCFPyL PET/CT in a Patient With Metastatic Renal Cell Carcinoma.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Lysine; Male; Middle Aged; Multimodal Imaging | 2016 |
PSMA-Targeted
Topics: Antigens, Surface; Autopsy; Biomarkers, Tumor; Carcinoma, Renal Cell; Cause of Death; Fatal Outcome; | 2017 |
Hand foot skin reaction in cancer patients treated with the multikinase inhibitors sorafenib and sunitinib.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antineoplastic Agents; Benzenesulfonates; Carcinom | 2008 |
Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma.
Topics: Adult; Aged; Carcinoma, Renal Cell; Cell Proliferation; Cell Survival; Docetaxel; Female; Glycogen S | 2009 |
RENAL ADENOCARCINOMA CONTAINING A PARATHYROID HORMONE-LIKE SUBSTANCE AND ASSOCIATED WITH MARKED HYPERCALCEMIA.
Topics: Adenocarcinoma; Alkaline Phosphatase; Antigens; Blood Chemical Analysis; Bone Neoplasms; Calcium; Ca | 1964 |